BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20980631)

  • 21. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
    Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
    Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
    D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
    J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.
    Najjar I; Baran-Marszak F; Le Clorennec C; Laguillier C; Schischmanoff O; Youlyouz-Marfak I; Schlee M; Bornkamm GW; Raphaël M; Feuillard J; Fagard R
    J Virol; 2005 Apr; 79(8):4936-43. PubMed ID: 15795279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
    Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-κB activation and the viability of EBV-transformed lymphoblastoid cell lines.
    Kim JE; Jun S; Song M; Kim JH; Song YJ
    Food Chem Toxicol; 2012 May; 50(5):1524-8. PubMed ID: 22387267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
    Middeldorp JM; Pegtel DM
    Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.
    Faumont N; Le Clorennec C; Teira P; Goormachtigh G; Coll J; Canitrot Y; Cazaux C; Hoffmann JS; Brousset P; Delsol G; Feuillard J; Meggetto F
    Cancer Res; 2009 Jun; 69(12):5177-85. PubMed ID: 19491276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification.
    Zauner L; Melroe GT; Sigrist JA; Rechsteiner MP; Dorner M; Arnold M; Berger C; Bernasconi M; Schaefer BW; Speck RF; Nadal D
    Oncogene; 2010 Aug; 29(32):4588-98. PubMed ID: 20514021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M; Lundgren E
    Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection.
    Takeda S; Miyazaki D; Sasaki S; Yamamoto Y; Terasaka Y; Yakura K; Yamagami S; Ebihara N; Inoue Y
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6729-36. PubMed ID: 21778270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S; Mattioli B; Galletti R; Samoggia P; Chichiarelli S; Mearini G; Mattia E
    Oncogene; 2002 Jun; 21(26):4166-70. PubMed ID: 12037673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
    Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
    Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
    Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.